Valsartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 43547-313

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Valsartan And Hydrochlorothiazide (NDC 43547-313). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Solco Healthcare Us, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

5a5eca60 Figure 01

This is a chart/table containing values of blood pressure expressed in mmHg (millimeters of mercury) for different dosages of Valsartan and Hydrochlorothiazide medications. The objective is to evaluate the efficacy of treatments in reducing blood pressure below 140 mmHg. The dosages include Valsartan-HCTZ 320/125 mg, Valsartan 320 mg, Hydrochlorothiazide 25 mg, and Placebo. The chart also shows the baseline SBP values for comparison.*

FDA Label Image

5a5eca60 Figure 02

This is a table of numerical data pertaining to blood pressure medication. The table lists the medication options, dosage, and baseline diastolic blood pressure (DBP) measurements in mmHg. The first medication option listed, Valsartan-HCTZ at a dosage of 320/25 mg, resulted in a DBP of 88 mmHg. The second medication option, A LA Valsartan at a dosage of 320 mg in combination with 25 mg of Hydrochlorothiazide, did not have a reported DBP measurement. The third option listed is a placebo. The baseline DBP measurement was 105 mmHg.*

FDA Label Image

5a5eca60 Figure 03

This appears to be a table or chart showing blood pressure readings at various levels, and the dosages of certain medications. It also includes the baseline blood pressure level. However, without additional context or information it is not possible to provide a more specific description of the data presented.*

FDA Label Image

5a5eca60 Figure 04

This appears to be a table showing the baseline DBP (diastolic blood pressure) in mmHg for different doses of Valsartan and Hydrochlorothiazide used in a study. The study is evaluating the effect of these medications in reducing DBP below 80 mmHg. The last row of the table is not labeled and its meaning is not clear.*

FDA Label Image

5a5eca60 Figure 05

FDA Label Image

5a5eca60 Figure 06

FDA Label Image

5a5eca60 Figure 07

This is a medication called Valsartan/Hydrochlorothiazide used to treat high blood pressure. Each tablet of this medication contains 80 mg of Valsartan USP and 125 mg of Hydrochlorothiazide USP. It should be stored at room temperature, between 20-25°C (68-77°F) and protected from moisture. The usual dosage is to be followed as per the package insert. This medication is manufactured by Zhejiang Hushai Pharmaceutical Co. Ltd in China and distributed by Soko Healthcare US, LLC from New Jersey, USA.*

FDA Label Image

5a5eca60 Figure 08

Each tablet contains 160mg of Valsartan USP and 125mg of Hydrochlorothiazide USP. It should be stored at 20 to 25°C and be protected from moisture. The drug should be kept out of reach of children and dispensed in a light container. The manufacturer of the tablets is Thejang Hushai Pharmaceuticals, based in China, and the drug is distributed by Soko Healthcare in the USA. There is also a note about the area to be left uncoated, but the context is not provided, so it may not be related to the drug.*

FDA Label Image

5a5eca60 Figure 09

This is a medication containing 160 mg of Valeartan USP and 25 mg of Hydrochlorothiazide USP. The usual dosage is mentioned on the package insert. It is recommended to store the medication at a temperature between 20-25°C (68-77°F), with excursions allowed to 15 and 30°C. The medication needs to be protected from moisture and should be dispensed in a tight container. The tablets are manufactured by Thejang Hushai Pharmaceutical Co. Ltd. and distributed by SokoHealtcare US, LLC in Somerset, NJ. It is important to keep this and all medication out of the reach of children. The box contains 30 tablets.*

FDA Label Image

5a5eca60 Figure 10

This is a medication containing 320mg of Valsartan USP and 12.5mg of Hydrochlorothiazide USP. The usual dosage instructions are not available in the text but are provided in the package. The medication should be stored at a temperature range of 20 to 25°C with excursions permitted between 15 and 30°C. It should be protected from moisture. The Medication is manufactured by Zhejiang Huahai Pharmaceutical Co., Ltd., located at Yungiao, Linha, Zhejing 317024, China. The medication is distributed by the company in Somerset, NJ, USA. The package contains 30 tablets.*

FDA Label Image

5a5eca60 Figure 11

This is a drug label for a medication containing 320mg of Valsaran USP and 25 mg of Hydrochlorothiazide USP. The recommended dosage is not mentioned and the user should refer to the package insert for the prescribed dosage. The medicine should be stored in a cool, dry place away from children. It is manufactured by Zhejang Hushai Pharmaceutical Co. Ltd in China and distributed by Soko Healthcare US LLC in the US. The label also mentions the revision date as 04/07/2021 and the product comes in a pack of 30 tablets.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.